Avenira Limited (ASX: AEV) Appoints John He as Executive Chairman and CEO to Accelerate Wonarah Phosphate Project Development and Strengthen Strategic Partnerships
By | ACB News – Australia China Business News Stock Market Team
ACB News, Sydney – 20 October 2025: Avenira Limited (ASX: AEV), an ASX-listed battery cathode and fertiliser project developer, announced the appointment of Mr. John He as Executive Chairman and Chief Executive Officer, effective from 17 October 2025. Ms. Stephanie Yuan, former Chair and CEO, will remain on the Board as a Non-Executive Director.
Mr. He brings extensive experience in strategy, capital markets, and resource-sector operations. He previously held senior roles with Roc Partners, PwC Australia’s M&A team, and Boston Consulting Group (BCG) in New York, and currently serves on the board of Nigerian lithium company Bullcrest. He holds an MBA from The Wharton School, University of Pennsylvania, and a Bachelor of Commerce from the University of Melbourne.
Under his contract, Mr. He will receive a base salary of AUD 250,000 per annum, a short-term incentive of up to 50%, and 24 million share options exercisable over three years (subject to shareholder approval).
The company also appointed Mr. Jason He as Executive Director. Ms. Ran Mo and Mr. Shixing Zhang have stepped down as Directors, with Ms. Mo continuing as Finance Manager to ensure operational continuity.
Deputy Executive Chairman Mr. Brett Clark said John He’s capital markets background and Jason He’s transactional expertise will strengthen Avenira’s leadership as it advances the Wonarah Phosphate Project and deepens its partnership with Hebang.
Mr. John He said his focus will be on accelerating project development, identifying early revenue opportunities, and building a sustainable growth path for shareholders.
Avenira Limited is a battery cathode and fertiliser project developer aiming to supply premium-quality products to the electric vehicle, agricultural, and industrial chemical markets through an integrated supply chain. Its flagship Wonarah Phosphate Project in Australia’s Northern Territory hosts one of the country’s largest phosphate resources—550 million tonnes across measured, indicated, and inferred categories—and benefits from proximity to the Northern Gas Pipeline, highway network, and reliable water resources.
The new leadership marks an important step in Avenira’s transition from resource developer to vertically integrated producer of high-value materials, including phosphate, yellow phosphorus, and LFP cathode materials for the global battery and fertiliser markets.
Disclaimer
The information provided on this website is for general informational purposes only and does not constitute financial or investment advice. While every effort is made to ensure accuracy, we do not guarantee the completeness, reliability, or timeliness of any content. Investment involves risk. Always seek independent, professional advice before making any financial decisions.
相关阅读

-
【异动股】和邦生物确认参与募资 磷酸盐矿企Avenira (ASX:AEV) 发起4900万澳元供股发行

-
【8.18】今日财经时讯及重要市场资讯

-
【3.3】今日财经时讯及重要市场资讯

-
【异动股】获最大股东四川和邦生物追投880万澳元 Avenira (ASX:AEV)澳洲Wonarah磷项目加足马力全力筹备2026年矿石直运

-
Avenira Limited (ASX: AEV) Appoints John He as Executive Chairman and CEO to Accelerate Wonarah Phosphate Project Development and Strengthen Strategic Partnerships

-
【10.20】今日财经时讯及重要市场资讯
免责声明:本网站信息仅供一般参考,不构成投资或财务建议。虽力求准确与完整,但不保证信息的准确性、完整性或时效性。投资有风险,决策前请咨询专业独立顾问。使用本网站即视为接受本免责声明。
热门点击
-
- Bell Potter持续看好ASX铜金矿股 美元“贬值交易”驱动黄金资产配置需求 铜已成市场共识性看多品种
-
- 【公司观察】得天时 占地利 聚人和 锁定矿石直销的Lithium Plus Minerals(ASX:LPM)正在打开怎样的成长空间?(下篇)
-
- 【9.14】今日财经时讯及重要市场资讯
-
- 【9.15】今日财经时讯及重要市场资讯
-
- 【异动股周报】CTD从27澳元做空到17澳分平仓背后 BUB婴配粉获美国FDA永久授权 煤炭股WEC百日暴涨逾6倍
-
- 【9.16】今日财经时讯及重要市场资讯
-
- 【异动股】TMK Energy(ASX:TMK)蒙古国煤层气产量再创新高 多井产气达到纪录水平
-
- 【异动股】富豪竞相押注铜矿 澳首富Gina Rinehart斥资880万认购White Cliff Minerals(ASX:WCN) 基石股份 超越其子成最大股东
-
- 【异动股】3千万到20亿澳元市值跨越仅用20个月!Minerals 260(ASX:MI6)再获黄金特许权巨头2亿澳元战略注资 续写高增长篇章
-
- New Hope煤业(ASX:NHC)FY26利润滑坡六成 成本上升啃噬业绩表现 盈利底部or趋势性恶化?
-
- 历史性转折:澳电动汽车单月销量首次超越传统燃油车
-
- 股债相关性翻转引发澳股估值逻辑重构 告别“追涨杀跌”之后选股策略何去何从
-
- 全球资金成本重定价直接冲击澳洲房地产市场 V型复苏或将渺茫?
-
- 【异动股】Telix Pharmaceuticals(ASX:TLX)脑癌成像药物Pixclara通过美国FDA新药申请 股价劲涨4%
-
- 三年内削减移民76.6万 一国党激进计划被指堪比COVID级别冲击

